5 completed, 3 terminated, 1 recruiting. 9 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Terminated 3, Recruiting 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Artificial Tears: new trials by email Literature Review of Artificial Tears trials Research Report on Artificial Tears
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema Surabgene Lomparvovec, Sham, Topical Steroid - Diabetic Retinopathy | Phase 2 / Phase 3 | Recruiting | AbbVie | 576 | 2026-06-01 | 2026-10-29 |
| Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution NCX 470, Placebo - Open Angle Glaucoma | Phase 2 / Phase 3 | Completed | Nicox Ophthalmics, Inc. | 18 | 2023-12-12 | 2025-09-08 |
| Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease licaminlimab, vehicle of OCS-02, Artificial tears - Dry Eye Disease | Phase 2 | Completed | Oculis | 122 | 2023-11-29 | 2025-07-02 |
| Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) SAF312 Placebo, SAF312 - Chronic Ocular Pain | Phase 2 | Completed | Novartis Pharmaceuticals | 153 | 2021-04-21 | 2024-10-09 |
| Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System Artificial Tears - Thyroid Carcinoma, Radioactive Iodine Level | Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 9 | 2020-10-05 | 2024-01-18 |
| Celecoxib for Thyroid Eye Disease Celecoxib, artificial tears - Thyroid Eye Disease | Phase 2 | Terminated | Johns Hopkins University | 7 | 2017-03-05 | 2020-07-31 |
| Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration Dorzolamide-timolol, Artificial tears - Neovascular Age-related Macular Degeneration, Wet Macular Degeneration | Phase 2 / Phase 3 | Completed | Wills Eye | 52 | 2017-02-08 | 2020-06-19 |
| Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis Ketotifen 4.0% Patch, Placebo, Olopatadine 0.2% - Allergic Conjunctivitis | Phase 2 | Completed | Senju USA, Inc. | 122 | 2009-02-01 | 2023-08-04 |
| Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease Euphrasia-based homeopathic therapy, Cyclosporin solution - Dry Eye Syndromes | Phase 2 | Terminated | University of Missouri-Columbia | 7 | 2007-12-01 | 2017-01-12 |
Dry Eye Syndromes (2) · Conjunctivitis, Allergic (1) · Diabetic Retinopathy (1) · Eye Pain (1) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Graves Ophthalmopathy (1) · Lacrimal Apparatus Diseases (1) · Macular Degeneration (1) · Thyroid Neoplasms (1) · Wet Macular Degeneration (1)
AbbVie (1) · Johns Hopkins University (1) · Nicox Ophthalmics, Inc. (1) · Novartis Pharmaceuticals (1) · Oculis (1) · Senju USA, Inc. (1) · University of Missouri-Columbia (1) · Vanderbilt-Ingram Cancer Center (1) · Wills Eye (1)
United States (9) · Japan (1) · Puerto Rico (1) · United Kingdom (1)
Gail Torkildsen, MD (1) · Jason Hsu, MD (1) · Lenworth N Johnson, MD (1) · Rachel Sobel, MD (1) · Sharon Klier, MD, MPH (1) · Timothy J McCulley, MD (1)